Study: Collagen/thrombin hemostasis gel is not warranted for routine THA
Los investigadores de un estudio de nivel 1 no encontraron diferencias estadísticas en los eventos de transfusión o unidades transfundidas sin cemento entre la artroplastia total de cadera (ATC) de los pacientes que se sometieron a la utilización de una trombina colágeno, fibrinógeno y gel de plaquetas autólogo para un adyuvante hemostático y un grupo control en el que norma se utilizaron los métodos hemostáticos.
Investigators of a level 1 study found no statistical difference in transfusion events or units transfused between cementless total hip arthroplasty (THA) patients who underwent the use of a collagen thrombin, fibrinogen and autologous platelet gel for a hemostatic adjuvant and a control group in which standard hemostatic methods were used. Read more
NEW ORLEANS — Investigators of a level 1 study from the Cleveland Clinic discovered no statistical difference in transfusion events or units transfused between cementless total hip arthroplasty patients who underwent the use of a collagen thrombin, fibrinogen and autologous platelet gel for a hemostatic adjuvant compared to a control group using standard hemostatic methods.
“We do not feel this product is clinically warranted for use in all total hips and further study would be needed to justify its use in patients with a higher risk of bleeding such as in revisions,” he said. – by Renee Blisard Buddle
Reference:
Joyce D. Paper #3. Presented at: American Academy of Orthopaedic Surgeons Annual Meeting; March 11-15, 2014; New Orleans.For more information:
David M. Joyce, MD, can be reached at 3601 The Vanderbilt Clinic, Nashville, TN 37232; email:david.m.joyce@vanderbilt.edu.Disclosure: Joyce has no relevant financial disclosures.
No hay comentarios:
Publicar un comentario